Our Partnership
Key Structures
Topics
Results & Data
Impact Stories
These Women Are Fighting Disease and Preparing for Future Health Threats
Genome Lab Technology Transforms Indonesia’s Response to Health Threats
Meet the People Behind the World’s Largest Mosquito Net Campaign
Tanzania’s First Line of Defense Against Pandemics: Neema Vulugu
News Releases
Global Fund and Unitaid Welcome WHO Recommendation for Insecticide-treated Nets …
Global Fund, USAID and Stop TB Partnership's New Collaboration With Molbio Diagn…
Global Fund Announces Additional Emergency Funding in Ukraine After One Year of …
Global Fund Provides US$867 Million in Additional Funding for Pandemic Preparedn…
Opinion
Tuberculosis: The Unseen Pandemic
In Côte d’Ivoire, Sex Workers Team Up With Police to Fight Stigma and HIV
The Criminalization of Sex Work Not Only Violates Human Rights – It Adds to HIV …
A Hotline Operator’s Tireless Efforts to Keep People on Drug Treatment Despite W…
Updates
Featured
Under the Global Fund funding model, every three years eligible countries are allocated funding for the disease components for which they are eligible – HIV, tuberculosis and/or malaria. Additional catalytic funding may also be available. Reference materials from past periods, including allocation lists, are available for download here. Historical eligibility data are available for download in the section titled Related Resources at the bottom of the page.
Investing funds raised during the Seventh Replenishment
Allocations & Transitions
Eligibility
Investing funds raised during the Sixth Replenishment
Allocations & Transitions
Eligibility
Funding
Investing funds raised during the Fifth Replenishment
Allocations
Funding
Investing funds raised during the Fourth Replenishment
Allocations
Funding
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.